Alpine Immune Sciences

Acquired
Seattle, Washington, US

Alpine Immune Sciences develops treatments for inflammatory diseases and cancer.

Facts

HQ
Seattle, Washington, US
Sectors
Biotechnology Research
Founded
2015
Type
Corporation Seattle business license
Employees
51–200
Status
Acquired
Registered name
Ais Operating Co Inc Seattle business license
Stage
Acquired
Members see funding amounts.
.

Is this your organization? Claim it

Recent coverage

Front-page news, podcasts and videos about Alpine Immune Sciences

See all 13

Notch Therapeutics raises $85M Series A (total $91M) to fund stem cell–derived T cell therapies and open Seattle lab

Notch Therapeutics raised an $85 million Series A, bringing total funding to $91 million, to advance stem cell–derived T cell immunotherapies and expand with a new Seattle research lab. The 2018-founded biotech plans to grow from 35 to about 100 employees by end of 2022 and is collaborating with Allogene Therapeutics on treatments for blood cancers.

Online

Questions about Alpine Immune Sciences

What is Alpine Immune Sciences?

Seattle, Washington, US

Who invested in Alpine Immune Sciences, and how much has it raised?

Members of Seattle Flow see Alpine Immune Sciences' funding rounds, amounts and investors on its Funding tab. Joining is free.

Where is Alpine Immune Sciences based?

Alpine Immune Sciences is headquartered in Seattle, Washington, US.

When was Alpine Immune Sciences founded?

Alpine Immune Sciences was founded in 2015.

How many people work at Alpine Immune Sciences?

Alpine Immune Sciences has 51–200 employees.